Probity Advisors, Inc. Johnson & Johnson Transaction History

Probity Advisors, Inc.

$515 Million
Q3 2024

A detailed history of Probity Advisors, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Probity Advisors, Inc. holds 10,707 shares of JNJ stock, worth $1.57 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares

10,707

Previous 10,528 1.7%

Holding current value

$1.57 Million

Previous $1.54 Million 12.81%

% of portfolio

0.34%

Previous 0.32%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 16, 2024	BUY	$145.48 - $167.38 $26,040 - $29,961	179 Added 1.7%	10,707 $1.74 Million
Q2 2024 Aug 14, 2024	BUY	$144.38 - $157.78 $2,165 - $2,366	15 Added 0.14%	10,528 $1.54 Million
Q1 2024 May 02, 2024	BUY	$155.22 - $162.74 $18,005 - $18,877	116 Added 1.12%	10,513 $1.66 Million
Q4 2023 Feb 12, 2024	SELL	$145.6 - $158.88 $50,232 - $54,813	-345 Reduced 3.21%	10,397 $1.63 Million
Q3 2023 Nov 14, 2023	BUY	$155.75 - $174.48 $10,902 - $12,213	70 Added 0.66%	10,742 $1.67 Million
Q2 2023 Aug 10, 2023	SELL	$154.35 - $166.11 $86,899 - $93,519	-563 Reduced 5.01%	10,672 $1.77 Million
Q4 2022 Feb 14, 2023	SELL	$160.2 - $179.79 $35,564 - $39,913	-222 Reduced 1.94%	11,235 $1.98 Million
Q3 2022 Nov 14, 2022	SELL	$161.33 - $179.52 $119,222 - $132,665	-739 Reduced 6.06%	11,457 $1.87 Million
Q2 2022 Aug 12, 2022	SELL	$168.19 - $186.01 $78,376 - $86,680	-466 Reduced 3.68%	12,196 $2.17 Million
Q1 2022 May 10, 2022	SELL	$158.14 - $179.59 $87,925 - $99,852	-556 Reduced 4.21%	12,662 $2.24 Million
Q4 2021 Feb 10, 2022	SELL	$155.93 - $173.01 $32,589 - $36,159	-209 Reduced 1.56%	13,218 $2.26 Million
Q3 2021 Oct 08, 2021	BUY	$161.5 - $179.47 $50,388 - $55,994	312 Added 2.38%	13,427 $2.17 Million
Q2 2021 Aug 06, 2021	BUY	$159.48 - $171.07 $28,387 - $30,450	178 Added 1.38%	13,115 $2.16 Million
Q1 2021 Apr 28, 2021	SELL	$153.07 - $170.48 $47,451 - $52,848	-310 Reduced 2.34%	12,937 $2.13 Million
Q3 2020 Nov 09, 2020	SELL	$140.38 - $153.83 $14,038 - $15,383	-100 Reduced 0.75%	13,247 $1.97 Million
Q2 2020 Aug 03, 2020	BUY	$128.81 - $155.51 $24,216 - $29,235	188 Added 1.43%	13,347 $1.88 Million
Q1 2020 May 15, 2020	SELL	$111.14 - $153.99 $6,446 - $8,931	-58 Reduced 0.44%	13,159 $1.73 Million
Q4 2019 Feb 13, 2020	SELL	$127.5 - $146.44 $14,280 - $16,401	-112 Reduced 0.84%	13,217 $1.93 Million
Q3 2019 Nov 14, 2019	BUY	$126.95 - $142.14 $3,427 - $3,837	27 Added 0.2%	13,329 $1.73 Million
Q2 2019 Aug 08, 2019	SELL	$131.15 - $144.24 $44,853 - $49,330	-342 Reduced 2.51%	13,302 $1.85 Million
Q1 2019 Apr 29, 2019	BUY	$125.72 - $139.79 $37,464 - $41,657	298 Added 2.23%	13,644 $1.91 Million
Q4 2018 Feb 12, 2019	SELL	$122.84 - $147.84 $31,447 - $37,847	-256 Reduced 1.88%	13,346 $1.72 Million
Q3 2018 Nov 14, 2018	SELL	$121.58 - $142.88 $11,550 - $13,573	-95 Reduced 0.69%	13,602 $1.88 Million
Q2 2018 Aug 13, 2018	BUY	$119.4 - $131.76 $25,671 - $28,328	215 Added 1.59%	13,697 $1.66 Million
Q1 2018 Apr 16, 2018	SELL	$125.1 - $148.14 $7,756 - $9,184	-62 Reduced 0.46%	13,482 $1.73 Million
Q4 2017 Feb 09, 2018	SELL	$131.22 - $143.62 $45,533 - $49,836	-347 Reduced 2.5%	13,544 $1.89 Million
Q3 2017 Oct 27, 2017	BUY	$129.47 - $135.38 $1.8 Million - $1.88 Million	13,891	13,891 $1.81 Million

Others Institutions Holding JNJ

# of Institutions

4,272

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $383B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Probity Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Probity Advisors, Inc. with notifications on news.

Account

Probity Advisors, Inc. Johnson & Johnson Transaction History